Table 2.
Survival analysis
| Items | N (survival rate) | Log rankp | HR | 95% CI | P |
|---|---|---|---|---|---|
| Age: (yr) | |||||
| ≤ 60 yr |
15 (13.3%) |
0.617 |
0.822 |
0.374-1.808 |
0.627 |
| > 60 yr |
15 (20.0%) |
||||
| Gender: n(%) | |||||
| Male |
27 (18.5%) |
0.725 |
0.809 |
0.238-2.748 |
0.734 |
| Female |
3 (0) |
||||
| CEA | |||||
| Normal |
23 (13.0%) |
0.499 |
0.716 |
0.265-1.936 |
0.497 |
| Increased |
7 (28.6%) |
||||
| AFP | |||||
| Normal |
24 (16.7%) |
0.728 |
1.185 |
0.443-3.172 |
0.736 |
| Increased |
6 (16.7%) |
||||
| CA19-9 | |||||
| Normal |
22 (13.6%) |
0.527 |
0.748 |
0.297-1.886 |
0.538 |
| Increased |
8 (25.0%) |
||||
| Ascites | |||||
| Yes |
7 (17.4%) |
0.793 |
1.127 |
0.449-2.833 |
0.799 |
| No |
23 (14.3%) |
||||
| Primary tumor size | |||||
| < 5cm |
18 (22.2%) |
0.984 |
1.008 |
0.454-2.236 |
0.985 |
| ≥ 5cm |
12 (8.3%) |
||||
| Number of liver metastasis | |||||
| Single |
22 (22.2%) |
*0.028 |
2.456 |
1.048-5.756 |
*0.039 |
| Multiple |
8 (8.3%) |
||||
| Liver metastasis size | |||||
| < 5cm |
14 (21.4%) |
0.766 |
1.124 |
0.509-2.482 |
0.772 |
| ≥ 5cm |
16 (12.5%) |
||||
| Peritoneal metastasis | |||||
| P1 |
5 (20.0%) |
*0.007 |
3.836 |
1.292-11.383 |
*0.015 |
| P0 |
25 (0) |
||||
| Liver surgery | |||||
| Lobectomy |
23 (17.4%) |
0.944 |
1.032 |
0.411-2.593 |
0.946 |
| Partial hepatotrectomy |
7 (14.3%) |
||||
| T stage: n(%) | |||||
| T1, T2 |
4 (50.0%) |
0.508 |
0.757 |
0.324-1.767 |
0.519 |
| T3, T4 |
26 (11.5%) |
||||
| N metastasis: n(%) | |||||
| Negative |
7 (14.3%) |
0.574 |
1.293 |
0.515-3.249 |
0.584 |
| Positive |
23 (17.4%) |
||||
| Tumor embolus | |||||
| Yes |
13 (15.4%) |
0.650 |
1.196 |
0.541-2.647 |
0.658 |
| No |
17 (17.6%) |
||||
| Tumor differentiation | |||||
| Well-intermediately differentiation |
7 (28.6%) |
0.379 | 1.535 | 0.573-4.112 | 0.394 |
| Poorly differentiated | 23 (13.0%) | ||||